Chen Haoyu, Yang Jimeng, Shao Yongfeng, Gu Weidong, Ni Buqing, Gu Jiaxi, Chen Minglong, Li Mingfang
Division of Cardiology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Division of Cardiac Surgery, the First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
J Cardiothorac Surg. 2025 Aug 9;20(1):330. doi: 10.1186/s13019-025-03573-w.
This study evaluated the impact of atrial fibrillation (AF) recurrence during the "blanking period" following thoracoscopic ablation on long-term AF recurrence.
This prospective observational study enrolled consecutive patients who underwent thoracoscopic AF ablation at our center between 2013 and 2020. Patients were grouped based on AF recurrence during the 3-month blanking period: no recurrence (Group A), early recurrence only (0-7 days, Group B), late recurrence only (8 days-3 months, Group C), or both early and late recurrence (Group D). The primary endpoint was long-term AF recurrence.
We finally analyzed 171 patients (mean age 62.5 ± 8.4 years, 34.5% female). During the blanking period, 118 patients (69.0%) experienced recurrent AF, distributed as follows: 57 in Group B, 35 in Group C, and 26 in Group D. During the median follow-up of 42.3 months (interquartile range: 25.0-60.4 months), post-blanking AF recurrence occurred in 85 patients (49.7%). Group A had the lowest post-blanking recurrence rate. Recurrence in any form (Groups B, C, or D) was associated with a significantly increased risk of long-term AF recurrence compared to Group A (adjusted HR 2.43, 95% CI 1.40-4.24, P = 0.002). Furthermore, Group B had a lower post-blanking recurrence rate (adjusted HR 0.58, 95% CI 0.35-0.97, P = 0.04) compared to Groups C and D.
Late recurrence during the blanking period is a strong predictor of long-term AF recurrence, suggesting the need for closer monitoring and early intervention for patients with late recurrence during the blanking period after thoracoscopic AF ablation.
本研究评估了胸腔镜消融术后“空白期”房颤(AF)复发对长期AF复发的影响。
这项前瞻性观察性研究纳入了2013年至2020年间在本中心接受胸腔镜AF消融术的连续患者。根据3个月空白期内的AF复发情况对患者进行分组:无复发(A组)、仅早期复发(0 - 7天,B组)、仅晚期复发(8天 - 3个月,C组)或早期和晚期均复发(D组)。主要终点是长期AF复发。
我们最终分析了171例患者(平均年龄62.5±8.4岁,女性占34.5%)。在空白期内,118例患者(69.0%)经历了AF复发,分布如下:B组57例,C组35例,D组26例。在中位随访42.3个月(四分位间距:25.0 - 60.4个月)期间,85例患者(49.7%)出现了空白期后AF复发。A组的空白期后复发率最低。与A组相比,任何形式的复发(B组、C组或D组)均与长期AF复发风险显著增加相关(校正后HR 2.43,95%CI 1.40 - 4.24,P = 0.002)。此外,与C组和D组相比,B组的空白期后复发率较低(校正后HR 0.58,95%CI 0.35 - 0.97,P = 0.04)。
空白期内的晚期复发是长期AF复发的有力预测指标,提示对于胸腔镜AF消融术后空白期出现晚期复发的患者需要进行更密切的监测和早期干预。